You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP study): study protocol for a randomized controlled trial
|
|---|---|
| Published in |
BMC Psychiatry, March 2016
|
| DOI | 10.1186/s12888-016-0779-8 |
| Pubmed ID | |
| Authors |
Masaya Ito, Yasuyuki Okumura, Masaru Horikoshi, Noriko Kato, Yuki Oe, Mitsuhiro Miyamae, Naotsugu Hirabayashi, Ayako Kanie, Atsuo Nakagawa, Yutaka Ono |
| Abstract |
The unified protocol for the transdiagnostic treatment of emotional disorders is a promising treatment approach that could be applicable to a broad range of mental disorders, including depressive, anxiety, trauma-related, and obsessive-compulsive disorders. However, no randomized controlled trial has been conducted to verify the efficacy of the unified protocol on the heterogeneous clinical population with depressive and anxiety disorders. The trial was designed as a single-center, assessor-blinded, randomized, 20-week, parallel-group superiority study in order to compare the efficacy of the combination of unified protocol and treatment-as-usual versus waiting-list with treatment-as-usual for patients with depressive and/or anxiety disorders. The primary outcome was depression at 21 weeks, assessed by the 17-item version of the GRID-Hamilton Rating Scale for Depression. Estimated minimum sample size was 27 participants in each group. We will also examine the treatment mechanisms, treatment processes, and neuropsychological correlates. The results of this study will clarify the efficacy of the unified protocol for depressive and anxiety disorders, and the treatment mechanism, process, and neurological correlates for the effectiveness of the unified protocol. If its efficacy can be confirmed, the unified protocol may be of high clinical value for Japan, a country in which cognitive behavioral treatment has not yet been widely adopted. ClinicalTrials.gov NCT02003261 (registered on December 2, 2013). |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 20% |
| Japan | 1 | 20% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 159 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 14% |
| Researcher | 19 | 12% |
| Student > Ph. D. Student | 14 | 9% |
| Student > Bachelor | 12 | 7% |
| Student > Doctoral Student | 9 | 6% |
| Other | 33 | 20% |
| Unknown | 52 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 56 | 35% |
| Medicine and Dentistry | 19 | 12% |
| Social Sciences | 5 | 3% |
| Nursing and Health Professions | 4 | 2% |
| Unspecified | 3 | 2% |
| Other | 12 | 7% |
| Unknown | 62 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2016.
All research outputs
#7,980,968
of 25,600,774 outputs
Outputs from BMC Psychiatry
#2,845
of 5,491 outputs
Outputs of similar age
#104,666
of 315,885 outputs
Outputs of similar age from BMC Psychiatry
#47
of 94 outputs
Altmetric has tracked 25,600,774 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 5,491 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.3. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,885 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.